#United States #New York #AI Clinical Intelligence #Navina #Joshua Newman

Dr. Joshua Newman's Appointment at Navina

In a strategic move poised to amplify its impact on healthcare, Navina has announced the appointment of Dr. Joshua Newman as Chief Medical Officer (CMO). With an impressive portfolio that includes nearly 14 years at Salesforce and roles in healthcare technology, Dr. Newman is set to lead Navina’s clinical vision and further strengthen its AI-powered platform.

Experience that Matters

Dr. Newman brings a unique blend of clinical and technological expertise that is especially beneficial for Navina, an organization dedicated to enhancing clinical intelligence through artificial intelligence. His career trajectory has taken him from frontline medicine to high-level executive positions, ensuring that he understands the needs of healthcare providers from multiple perspectives.

Previously serving as the Senior Vice President and CMO at Salesforce, Dr. Newman helped develop the company’s healthcare initiatives, fostering relationships with health systems and payers alike. His role at Alleviate.care as Chief Strategy Officer further cemented his reputation as a leader in healthcare innovation. He has also made significant contributions to medical academia as an assistant professor of medicine at UCLA.

“Dr. Newman's deep expertise and commitment to advancing technology in the healthcare industry is a perfect fit for the next phase of Navina's growth and development,” said Ronen Lavi, Co-founder and CEO of Navina. This sentiment highlights the company’s aspirations of marrying clinical experience with cutting-edge technology.

Impacting Healthcare Delivery

As CMO, Dr. Newman will oversee the implementation of Navina's clinical intelligence platform across a growing number of healthcare environments. Currently, the platform serves over 20,000 clinicians and care team members across 1,300 clinics nationwide, ultimately benefiting over five million patients. His goal is to ensure that the physician's perspective remains at the forefront of product development, a vision deeply rooted in his own experience.

Dr. Newman emphasizes the critical importance of effective information management in modern healthcare, stating, "Value-based care asks clinicians to act on information that is scattered across thousands of pages of records, and then punishes them with documentation work when they do." His assertions speak to a broader industry need: the necessity for more streamlined, user-friendly solutions that enhance care while reducing the administrative burdens that currently plague healthcare providers.

Advancing Population Health

Navina’s AI-enhanced platform is not just about improving workflow; it’s about fundamentally changing how care is delivered. By enabling proactive care from the outset and minimizing retrospective processes, the platform supports confident, data-driven decisions that are crucial for today’s value-based care models. The impressive 86% utilization rate of Navina’s system underscores its effectiveness and the commitment of providers to make the most out of available tools.

As Navina continues to experience rapid growth, Dr. Newman will also collaborate closely with the company’s marketing and customer support teams to ensure alignment with client needs and industry trends. His expertise will guide conversations around AI adoption in healthcare, fostering an environment where technology can significantly improve both population health and patient outcomes.

A Bright Future Ahead

With accolades such as being named Best in KLAS for Clinician Digital Workflow in 2025 and receiving recognition as one of TIME's World’s Top HealthTech Companies of 2026, Navina is positioned as a key player in the healthcare technology landscape. Dr. Newman's leadership is expected to further solidify this position, guiding the company through its next chapter of innovation.

To learn more about Navina and its commitment to transforming clinical practice through AI, visit www.navina.ai.

In summary, the inclusion of Dr. Joshua Newman as CMO marks a significant milestone for Navina as it continues to prioritize the needs of clinicians and patients alike, pushing the boundaries of what is possible in the realm of clinical intelligence.